Statistics from Altmetric.com
We introduced surfactant administration via supraglottic airway (otherwise known as the laryngeal mask airway or LMA) to treat respiratory distress syndrome (RDS) in infants greater than 1.2 kg in two Scottish neonatal units (level 3 and level 2). We report the outcomes of the first 60 infants treated between December 2018 and May 2020.
Prior to implementation a comprehensive review of available evidence was undertaken,1 including five randomised controlled trials (n=307) all of whom demonstrated a reduction in need for intubation and ventilation in treated infants. Adverse events were minimal, and the technique was reported as well tolerated by infants and easy for staff to learn. We wrote a guideline,2 and developed multimedia teaching materials that complemented simulation training with mannikins. …
Twitter @smee_natalie, @oshea_jem
Contributors NJS and JOS wrote the first draft of the manuscript. All authors are responsible for the reported research. All authors have participated in the concept and design; analysis and interpretation of data; and drafting or revising the manuscript. All authors have approved the manuscript as submitted.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Parental/guardian consent obtained.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.